Vascular complications of isolated limb perfusion

被引:18
作者
Klicks, RJ [1 ]
Vrouenraets, BC [1 ]
Nieweg, OE [1 ]
Kroon, BBR [1 ]
机构
[1] Netherlands Canc Inst, Antoni Van Leeuwenhoek Ziekenhuis, Dept Surg, NL-1066 CX Amsterdam, Netherlands
来源
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY | 1998年 / 24卷 / 04期
关键词
isolated limb perfusion; vascular complications; melanoma; sarcoma;
D O I
10.1016/S0748-7983(98)80008-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Isolated limb perfusion (ILP) is a complex vascular procedure which uses an extracorporeal circuit with high doses of cytostatic drugs and often hyperthermia for the treatment of extremity tumours. Our study investigated the incidence, treatment and subsequent outcome of vascular complications after ILP, about which little is known. Methods: A retrospective study was performed, in which we found 10 vascular complications after 466 ILPs (2.1%). Results: In eight patients, acute arterial obstruction developed in the immediate post-operative period, resulting from a thrombus at the arteriotomy site. Prompt reintervention with thrombectomy restored the circulation in all patients. One patient developed an arterial thrombus in the brachial artery due to compression of the surrounding tumour 12 days after ILP, which was successfully treated with thrombectomy and freeing the artery from the tumour. One patient was treated conservatively for digital micro-emboli. All complications occurred in women, maybe because of their generally smaller vessel size. No limbs were lost and all patients were free of any vascular problem after a median follow-up of 3.6 years. Conclusions: We conclude that vascular complications after ILP are rare, consist mainly of thrombosis at the arteriotomy site and can be successfully treated by prompt thrombectomy. Therefore, close observation of the peripheral circulation after ILP is necessary.
引用
收藏
页码:288 / 291
页数:4
相关论文
共 28 条
[11]  
KREMENTZ ET, 1986, CANCER, V57, P416, DOI 10.1002/1097-0142(19860201)57:3<416::AID-CNCR2820570304>3.0.CO
[12]  
2-M
[13]  
KREMENTZ ET, 1983, RECENT RES CANCER, V86, P193
[14]  
KRIGE JEJ, 1988, EUR J SURG ONCOL, V14, P321
[15]  
KROON BBR, 1988, EUR J SURG ONCOL, V14, P101
[16]   HIGH-DOSE RECOMBINANT TUMOR-NECROSIS-FACTOR-ALPHA IN COMBINATION WITH INTERFERON-GAMMA AND MELPHALAN IN ISOLATION PERFUSION OF THE LIMBS FOR MELANOMA AND SARCOMA [J].
LIENARD, D ;
EWALENKO, P ;
DELMOTTE, JJ ;
RENARD, N ;
LEJEUNE, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :52-60
[17]   CARBON-DIOXIDE LASER-ABLATION AS AN ALTERNATIVE TREATMENT FOR CUTANEOUS METASTASES FROM MALIGNANT-MELANOMA [J].
LINGAM, MK ;
MCKAY, AJ .
BRITISH JOURNAL OF SURGERY, 1995, 82 (10) :1346-1348
[18]  
MUCHMORE JH, 1987, AM SURGEON, V53, P94
[19]  
ROCHLIN DB, 1965, CANCER, V18, P1544, DOI 10.1002/1097-0142(196512)18:12<1544::AID-CNCR2820181205>3.0.CO
[20]  
2-X